Furthermore, Brg-1 has been demonstrated to be silenced or mutated in various human tumor cell lines derived from breast, ovarian, lung, brain and colon cancers [71], and the loss of Brg-1 expression is associated with a poor prognosis in lung cancer patients [72]. This evidence concerns the gene SMARCA4 and neoplasm.